Research

AI/tech still offers the best setup where scheduled disclosures can turn hidden infrastructure exposure into separately underwritable earnings power. The obvious AI winners remain crowded and price-sensitive, while cybersecurity and software need cleaner evidence that AI is adding durable ARR rather than just preserving multiples. The next real opportunity likely comes from spin disclosures, backlog quality, or guidance that proves margin-accretive AI revenue rather than headline demand.

Mega-cap tech remains fundamentally strong but crowded. Current official disclosures point to real AI demand and monetization, while also showing capital intensity, financing needs, accounting noise, and regulatory exposure that complicate clean underwriting. The attractive hunting ground is still segment-level proof that incremental AI revenue converts to durable cash flow faster than the market expects, not generic exposure to AI infrastructure or platform scale.

The biotech opportunity set is still rich in dated catalysts but not broadly attractive at a high-conviction long-term bar. The best hunting ground remains funded late-stage companies with primary-source regulatory dates or pivotal readouts where the market is mispricing commercial probability rather than merely assigning binary trial risk. I would avoid thinly financed single-asset stories unless a partnership, cash floor, or post-event overreaction materially changes the downside shape.

Energy remains fertile for research, but the cleanest data-center power and grid beneficiaries now disclose the upside plainly, reducing mispricing. The most attractive hunting ground is still contracted power, transmission bottlenecks, domestic electrical supply chains, and U.S. solar manufacturing with policy protection. Lower-quality storage, residential solar, and uranium ramp stories have visible catalysts but still carry too much execution or commodity dependence for a high-confidence new idea today.

The best current hunting ground remains emerging-tech companies where customer-funded demand is already visible and near-term disclosures can prove conversion into revenue, margin, or cash flow. Space and defense-autonomy look more evidence-backed than quantum, speculative nuclear, and battery pre-commercial stories, but price discipline is still the constraint. A real opportunity would need both dated proof of execution and a valuation reset.

The broad universe still offers the best raw material in asset-backed shipping, contracted infrastructure, defense production capacity and cash-generative materials businesses. The problem is catalyst quality: many candidates have good current fundamentals, but the next observable events are ordinary earnings, discretionary repurchases, commodity-rate moves or management-guided improvements rather than a hard valuation unlock. A sharper price reset, binding contract award, scheduled investor-day reset or asset-sale/deleveraging event would improve the opportunity set.